BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7527366)

  • 1. Standardization of immunoassays for antiphospholipid antibodies with beta 2GPI and role of other phospholipid cofactors.
    Amiral J; Larrivaz I; Cluzeau D; Adam M
    Haemostasis; 1994; 24(3):191-203. PubMed ID: 7527366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificities and characteristics of beta 2 glycoprotein I-induced antiphospholipid antibodies.
    Gharavi AE; Sammaritano LR; Bovastro JL; Wilson WA
    J Lab Clin Med; 1995 Jun; 125(6):775-8. PubMed ID: 7769372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some 'antiphospholipid antibodies' bind to beta 2-glycoprotein I in the absence of phospholipid.
    Keeling DM; Wilson AJ; Mackie IJ; Machin SJ; Isenberg DA
    Br J Haematol; 1992 Nov; 82(3):571-4. PubMed ID: 1486037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in beta 2-glycoprotein I antigenicity induced by phospholipid binding.
    Wagenknecht DR; McIntyre JA
    Thromb Haemost; 1993 Apr; 69(4):361-5. PubMed ID: 7684533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure of anionic phospholipids upon platelet activation permits binding of beta 2 glycoprotein I and through it that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects.
    Vázquez-Mellado J; Llorente L; Richaud-Patin Y; Alarcón-Segovia D
    J Autoimmun; 1994 Jun; 7(3):335-48. PubMed ID: 7916907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to beta 2-glycoprotein-I: urea resistance, binding specificity, and association with thrombosis.
    Vlachoyiannopoulos PG; Petrovas C; Tektonidou M; Krilis S; Moutsopoulos HM
    J Clin Immunol; 1998 Nov; 18(6):380-91. PubMed ID: 9857282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic characterization and functional properties of murine antibodies raised against deleted mutants of human beta 2-glycoprotein I.
    George J; Blank M; Gilburd B; Hojnik M; Shenkman B; Tamarin I; Varon D; Matsuura E; Koike T; Shoenfeld Y
    Int Immunol; 1997 Jun; 9(6):913-21. PubMed ID: 9199975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic role of antiprotein-phospholipid antibodies.
    Carreras LO; Forastiero RR
    Haemostasis; 1996 Oct; 26 Suppl 4():340-57. PubMed ID: 8979139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro.
    Di Simone N; Raschi E; Testoni C; Castellani R; D'Asta M; Shi T; Krilis SA; Caruso A; Meroni PL
    Ann Rheum Dis; 2005 Mar; 64(3):462-7. PubMed ID: 15256379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of antiphospholipid antibody ELISA cofactor in different animal sera.
    McCarthy JM; Wagenknecht DR; McIntyre JA
    J Clin Lab Anal; 1994; 8(3):167-71. PubMed ID: 8046545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lupus anticoagulant antibodies: recognition of phospholipid-binding protein complexes.
    Rauch J
    Lupus; 1998; 7 Suppl 2():S29-31. PubMed ID: 9814668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies.
    Pengo V; Biasiolo A; Brocco T; Tonetto S; Ruffatti A
    Thromb Haemost; 1996 May; 75(5):721-4. PubMed ID: 8725712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I.
    Roubey RA; Pratt CW; Buyon JP; Winfield JB
    J Clin Invest; 1992 Sep; 90(3):1100-4. PubMed ID: 1522218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when beta 2-glycoprotein I is bound to a suitable surface.
    Pengo V; Biasiolo A; Fior MG
    Thromb Haemost; 1995 Jan; 73(1):29-34. PubMed ID: 7537919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species specificity of anti-beta 2 glycoprotein I autoantibodies and its relevance to anticardiolipin antibody quantitation.
    Arvieux J; Darnige L; Hachulla E; Roussel B; Bensa JC; Colomb MG
    Thromb Haemost; 1996 May; 75(5):725-30. PubMed ID: 8725713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiphospholipid and anti beta 2-glycoprotein I antibodies].
    Arvieux J; Roussel B; Colomb MG
    Ann Biol Clin (Paris); 1994; 52(5):381-5. PubMed ID: 7856939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid antibodies and thrombosis.
    Brighton TA; Chesterman CN
    Baillieres Clin Haematol; 1994 Sep; 7(3):541-57. PubMed ID: 7841600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated anti-annexin V antibody levels in antiphospholipid syndrome and their involvement in antiphospholipid antibody specificities.
    Ogawa H; Zhao D; Dlott JS; Cameron GS; Yamazaki M; Hata T; Triplett DA
    Am J Clin Pathol; 2000 Oct; 114(4):619-28. PubMed ID: 11026109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.